GLP-1 Drugs

Written By Randy Wu

What are GLP-1 Drugs?

GLP-1 drugs are medications used to treat Type 2 diabetes and obesity. These drugs mimic the natural GLP-1 hormone in the body, helping regulate blood sugar levels, slow digestion, and reduce appetite. You have probably heard of Ozempic or Mounjaro, which have become popular because of their ability to help people quickly lose weight.

How do GLP-1 Drugs Relate to CVDs?

Obesity and diabetes are major risk factors for cardiovascular diseases, making up for 10% of CVD deaths. Because GLP-1 drugs lower blood sugar levels and promote weight loss, they can be beneficial for heart health and reduce the risk of cardiovascular complications. Research showed that semaglutide (GLP-1 drug) reduces the risk of heart attack, stroke, and cardiovascular death by 20%.

Cardiovascular Benefits from GLP-1 Drugs:

  • Lowering blood sugar levels

  • Reducing body weight

  • Decreasing inflammation

  • Improving blood vessel function

  • Lowering the risk of cardiovascular disease

Risks and Side Effects:

  • Nausea

  • Vomiting

  • Diarrhea

  • Constipation

  • Stomach Pain

  • Pancreatitis (<1%)

Most side effects are mild, by some patients may experience severe gastrointestinal symptoms or other complications.

GLP-1 drugs have become so popular over the past years that many are looking for a treatment option for obesity and diabetes. These medications don’t only help with weight loss and blood sugar control, but also reduce the risk of cardiovascular diseases. However, one of the major concerns with GLP-1 drugs is their high cost. Without insurance, GLP-1 drugs can cost over $1,000 per month, making it limited to some patients. Please consult a medical professional if you should take GLP-1 drugs.

Randy Wu
Previous

Cardiac Amyloidosis
Next

CardioMEMS HF System